Dow Down 0.92% Nasdaq Down 0.83%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
10.95 Down 0.60(5.19%) 4:00PM EDT
|After Hours : 10.86 Down 0.09 (0.82%) 5:45PM EDT - Nasdaq Real Time Price
Prev Close:11.55
Open:11.55
Bid:10.86 x 1000
Ask:11.36 x 500
1y Target Est:21.00
Beta:4
Next Earnings Date:N/A
Day's Range:10.90 - 11.57
52wk Range:6.52 - 15.80
Volume:1,298,880
Avg Vol (3m):1,571,480
Market Cap:661.36M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INODown 5.19%661.36M
AZNDown 0.32%86.87B
PFEUp 0.07%179.45B
SNYUp 0.92%138.11B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., together with its subsidiaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback